Showing 1311-1320 of 3475 results for "".
Targeting Cellulite: Evolving Approaches
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/targeting-cellulite-evolving-approaches/23796/New treatments mean that dermatologists can improve treatment outcomes for the 90% of women who have cellulite.New Frontiers in Skin Cancer Management
https://practicaldermatology.com/topics/skin-cancer-photoprotection/new-frontiers-in-skin-cancer-management/57249/Across the spectrum of diagnosis, prognostication, prevention, and treatment, advances in technology and therapeutics are reshaping how clinicians care for patients with skin cancer. This issue highlights innovations and insights that are changing the field and offers a glimpse of where skin cancerA Nose for Disease: A Review of Olfactory-Based Diagnosis in Dermatology
https://practicaldermatology.com/topics/infections-infectious-disease/a-nose-for-disease-a-review-of-olfactory-based-diagnosis-in-dermatology/23650/Despite technological advancements in diagnosis, the sense of smell can still be a helpful tool in the medical clinic.Treatment Guidelines for the PicoWay® Laser System in Skin of Color
https://practicaldermatology.com/topics/general-topics/treatment-guidelines-for-the-picoway-laser-system-in-skin-of-color/22087/Picosecond laser therapy for benign pigmented lesionsThe Future of Atopic Dermatitis Therapy
https://practicaldermatology.com/topics/general-topics/the-future-of-atopic-dermatitis-therapy/21143/As new research elucidates the individual mechanisms of atopic dermatitis, the development of therapies that more directly influence the disease may change the scope of treatment.Next-Generation TYK2 Inhibitors in Psoriasis
https://practicaldermatology.com/topics/psoriasis/next-generation-tyk2-inhibitors-in-psoriasis/60985/Phase 3 clinical data and emerging therapeutic implications demonstrate the promise of zasocitinib and envudeucitinib.Verrucous Psoriasis
https://practicaldermatology.com/topics/psoriasis/verrucous-psoriasis/27148/Verrucous psoriasis (VP) is a rare subtype of psoriasis most commonly affecting middle-aged to older adults, with fewer than 35 reported cases within the current literature. It is characterized by symmetric wart-like, hyperkeratotic, papillomatous plaques. Treatment options are limited and variable,Metabolomics Highlights: The Importance of Circadian Rhythm in Skin
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/metabolomics-highlights-the-importance-of-circadian-rhythm-in-skin/23126/New insights on the critical role of maintaining the natural rhythm of skin protection and repair.Sclerodermoid Reaction Due to Injection of Fish Oil
https://practicaldermatology.com/youngmd-connect/resident-resource-center/sclerodermoid-reaction-due-to-injection-of-fish-oil/20574/Subcutaneous Sarcoidosis Diagnosed in a 55-Year-Old Female
https://practicaldermatology.com/youngmd-connect/resident-resource-center/subcutaneous-sarcoidosis-diagnosed-in-a-55-year-old-female/22084/